Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Pharmacogenetics of capecitabine in advanced breast cancer patientsRémy Largillier, Marie-Christine Etienne-Grimaldi, Jean-Louis Formento, et al.
Antiviral Research|March 6, 2020
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primatesVincent Madelain, Aurélie Duthey, France Mentré, et al.
Therapeutic Drug Monitoring|August 4, 2006
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasmaSébastien Salas, Cédric Mercier, Joseph Ciccolini, et al.
Therapeutic Drug Monitoring|April 22, 2006
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicitiesCédric Mercier, Joseph Ciccolini, Bertrand Pourroy, et al.
Oncotarget|May 20, 2017
Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patientsFabrice Barlesi, Diane-Charlotte Imbs, Pascale Tomasini, et al.
Cancer Chemotherapy and Pharmacology|March 6, 2010
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicityChen Guang Yang, Joseph Ciccolini, Aurore Blesius, et al.
Plos One|January 4, 2013
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" studySophie Perrin, Jonathan Cremer, Olivia Faucher, et al.
Substance Abuse|December 15, 2020
Perception of pharmacy students toward opioid-related disorders and roles of community pharmacists: A French nationwide cross-sectional studyDavid Balayssac, Bruno Pereira, Pierre Cuq, et al.
Pageof 9